AlJadaan: Leaders of Gulf Countries are Keen for Gulf Cooperation Council to Reach Highest Levels of Economic Integration    1.5m clients benefit from digital conveyance of title deeds service    Umrah companies obligated to issue permits for its pilgrims    Saudi Arabia retains its seat in ITU Council by international consensus    RCU launches Safar art exhibition at AlUla airport    Iran's supreme leader blames unrest on US and Israel    Speaker of Shura Council Heads Kingdom's Delegation to 8th G20 Parliamentary Speakers' Summit in Jakarta    Saudi Stock Exchange Main Index Ends Trading Higher at 11,607.96 Points    Saudi Minister of Commerce Heads Delegation to Morocco, Discusses Enhancing Commercial, Investment Relations    Qatar Stock Exchange Ends Trading Higher    Saudi Arabia to host World Petroleum Congress in 2026    Jazan International Forum moots Saudi Coffee Day, Annual Coffee Award    Sultan Humanitarian City wins platinum award at 2022 Patient Safety Congress in Dubai    King, Crown Prince congratulate German president on Unity Day    Brazil election: Lula and Bolsonaro to face run-off    UK chancellor U-turns on plans to scrap tax rate    Record avian flu outbreak sees 48 million birds culled in UK and EU    Fans 'died in the arms' of players in Indonesia stadium crush    Fans of Sydney United 58 condemned for Nazi salutes during Australia Cup final    Tadawul All Share Index Decreases by 0.79%, Equity Market Capitalization Reaches SAR 10,832.85 Billion at End of 1st Nine Months 2022    Asian Shares Mostly Lower    Weather Forecast for Monday    KSrelief Concludes the 11th, 12th Volunteer Program in Zaatari Camp for Syrian Refugees in Jordan    flynas Launches the "Future Engineers Program" for Aircraft Engineering and Maintenance with 300 Saudi Engineers in Its First Batch    Al-Manea: Selling gold in installments is not permissible    MAWANI, Tabadul Sign MoU to Develop New Saudi Ports Management Systems    174 dead in Indonesian football stadium crush    At Least 127 People Killed, 180 Injured at Football Match in Indonesia    15 cups of Saudi coffee in a day are enough!    Riyadh hosts first Saudi Games on Oct. 27    19 women, 2 men qualify as Kingdom's first yogasana referees    Movies return to Kashmir with Hrithik Roshan-starrer    Body of famed US climber found on Mt Manaslu in Himalayas    Yoga introduced to Saudi universities    Islamic Minister Al-Sheikh: Juristic judgment catalyst to salvage Islamic Ummah    Culinary Arts Commission Registers 13 Foods on Slow Food List of Endangered Food    72% of Children Globally have been Victims of Cyber Threats    Saudi National Football Team Continues Preparations for Friendly Match against Ecuador    Saudi Futsal Team Beats San Marino, Wins Silver in Croatian International Championship    During 2nd Global AI Summit.. AI-powered Early Breast Cancer Detection Program Launched    Triple talaq: India Muslim women in limbo after instant divorce ruling    Film Commission Reviews Film Industry Prospects in Saudi Arabia at Venice International Film Festival    Saudi national volleyball team loses to Kyrgyzstan in Asian Challenge Cup final    Saudi national volleyball team beats Uzbekistan, qualifies for the final of the Asian Challenge Cup    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Pfizer says coronavirus vaccine is 100% effective in kids ages 12 to 15
Published in The Saudi Gazette on 31 - 03 - 2021

Clinical trial results of Pfizer/BioNTech's COVID-19 vaccine showed its efficacy is 100 percent and it is well tolerated in youths ages 12 to 15, the manufacturer said on Wednesday.
Pfizer/BioNTech plans to submit the data to the US Food and Drug Administration as soon as possible for expanded emergency use authorization of the two-dose vaccine.
In a Phase 3 trial of 2,260 participants ages 12 to 15 in the US, the vaccine elicited strong antibody responses one month after the second dose — exceeding those demonstrated in people ages 16 to 25 in previous trials, Pfizer reported. The vaccine is currently authorized in the US for emergency use in people 16 and older.
Researchers observed 18 COVID-19 cases among the 1,129 participants who were given a placebo, and none among the 1,131 volunteers who got the vaccine. The data has yet to be peer reviewed.
Pfizer/BioNTech added that the side effects seen in the young teens were similar to those seen among 16 to 25-year-olds. Common side effects include pain at the injection site, fatigue and fever. The participants will be monitored for protection and safety for two years after their second dose.
Those comparisons to the older population are important because researchers are building off of the knowledge they gained in the adult trials.
Researchers can define a number of antibodies that are a correlate of the protection seen in adults, and then look for that level of antibodies in pediatric participants to know that the vaccine is providing protection. That's why the COVID-19 vaccine trials in children and adolescents have generally required fewer volunteers than the adult trials.
"We share the urgency to expand the authorization of our vaccine to use in younger populations and are encouraged by the clinical trial data from adolescents between the ages of 12 and 15," said Pfizer CEO Albert Bourla.
"We plan to submit these data to FDA as a proposed amendment to our Emergency Use Authorization in the coming weeks and to other regulators around the world, with the hope of starting to vaccinate this age group before the start of the next school year."
Dr. William Gruber, Pfizer's senior vice president of vaccine clinical research and development also noted last week that the vaccine could be ready for this age group by the upcoming school year.
A return to the classroom isn't the only factor at play. Health experts have emphasized the importance of protecting as many people as possible through vaccination, as more infectious COVID-19 variants continue to spread throughout the nation.
"We all long for a normal life. This is especially true for our children," said BioNTech CEO Ugur Sahin. "The initial results we have seen in the adolescent studies suggest that children are particularly well protected by vaccination, which is very encouraging given the trends we have seen in recent weeks regarding the spread of the B.1.1.7 UK variant."
Pfizer recently told CNN that the safety demonstrated in this adolescent trial helped the company make the decision to begin testing its vaccine in younger children.
A separate Phase 1/2/3 study of the Pfizer/BioNTech vaccine in children ages 6 months to 11 years launched last week, when the first children ages 5 to 11 received a shot. Pfizer/BioNTech plans to begin dosing 2 to 5-year-olds next week and work its way down to participants ages 6 months to 2 years. The company aims to enroll 4,644 children in the trial and expects results by the end of 2021.
Moderna is also testing its vaccine in adolescents and children, in two clinical trials of children ages 12 to 17 and those ages 6 months to 11 years.
Experts anticipate Covid-19 vaccines won't be available for children 11 and younger in time for the upcoming school year. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has said those younger children may have to wait until the first quarter of 2022.
Dr. Buddy Creech, director of Vanderbilt University's Vaccine Research Program and an investigator in Moderna's pediatric trials, estimates a COVID-19 vaccine could be available for high-risk kids 12 and older by July or August, but likely won't be available for children 11 and younger until November or December, at the earliest. — Courtesy CNN


Clic here to read the story from its source.